Sharing details on the Special Drive for Adverse Drug Reaction (ADR) reporting and monitoring of drugs used in COVID-19, Dr Harsh Vardhan clarified that this special drive is not because of an adverse reaction reported with an existing drug, but is part of a proactive COVID-19 preparedness programme.